Therefore, the first objective of this study is to determine whether the scales of the CTRS-R, measuring ODD and ADHD behavior, are measurement invariant for gender of the student as well as gender of the teacher throughout primary school.
For many of the items on the risk assessment there is not a scale that determines whether the patient is placed in a category or diagnosed, with the exception of the suicide risk assessment tool that tallies up a score to determine whether the patient is a risk to him or herself or others.
All of the subjects in this study were recruited in a large city (Chongqing) in mainland China; determining whether the scale can be generalized to other regions will require further studies in other areas.
To further determine whether the GSE scale could distinguish people with different levels of general self-efficacy, person-separation reliability was assessed.
In doing so, our aim was to determine whether the Manchester scale would be a suitable tool for self-assessment of HV in the context of a postal survey of foot disorders.
For example, Kopec et al [ 4] reported a study that was conceived to "determine whether the Quebec scale (a functional status measure for patients with low-back pain) is a reliable, valid, and responsive measure of disability, in back pain, and to compare it with other disability scales".
This analysis was performed to determine whether the large-scale transcriptional modulation described above was translated into a correspondingly large-scale proteomic shift.
Next, we sought to determine whether the large-scale redistribution of SCML2AΔRBR that we observed by microscopy and biochemical fractionation was due to the loss of recruitment of SCML2A to target genes.
Caution should be exercised when utilising the Social & Family Well-being scale and further work is required to determine whether this scale is best represented by two factors.
The purpose of this study was to determine whether the bispectral index scale (BIS) would provide added benefit to established methods of monitoring conscious sedation with midazolam (M group) or midazolam supplemented with ketamine (MK group).
